fda lumipulse - Search News

News

Alzheimer's, FDA and blood

BioSpace · 38m

FDA Clears First Alzheimer’s Blood Test, Lending ‘Momentum’ to Lilly’s Kisunla, Biogen’s Leqembi

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s disease therapies.

Yahoo Finance · 4h

FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s

The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD) test for evaluating amyloid pathology in individuals under assessment for Alzheimer's disease and other cognitive decline causes.

The Washington Post on MSN · 2d

FDA endorses first-of-its-kind blood test for Alzheimer’s disease

The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less risky for patients with cognitive decline.

1don MSN

New Alzheimer's Test Approved by FDA—What to Know

The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

1don MSN

FDA greenlights first blood test to diagnose Alzheimer's disease

FDA approves Lumipulse G, the first blood test that can help in the diagnosis of Alzheimer's disease. Read more here.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results